Satoshi Tateshima, MD
Vascular & Interventional Radiology · Los Angeles, CANPI 1922042068
Payments from drug & device makers
Across 305 payments — averaging $3021.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Corindus Inc.$485K
- Rapid Medical Ltd$138K
- Stryker$126K
- Medical Device Business Services, Inc.$110K
- Medtronic$23K
- Viseon, Inc.$20K
- plus $18K from 15 others
Across 6 payments — averaging $779.17 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$5K
What the payments were for
- Consulting fees$187,78225%
- Speaking & faculty fees$5,9751%
- Travel & lodging$76,30710%
- Food & beverage$9,5961%
- Ownership interest$484,50063%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Corindus Inc. | 4 | $485,406 |
| Rapid Medical Ltd | 31 | $138,147 |
| Stryker | 117 | $125,701 |
| Medical Device Business Services, Inc. | 58 | $110,381 |
| Medtronic(2 entities) | 36 | $23,356 |
| Viseon, Inc. | 4 | $20,403 |
| Microvention, Inc. | 15 | $9,088 |
| Penumbra, Inc. | 3 | $2,052 |
| Nippon Boehringer Ingelheim Co., Ltd. | 1 | $1,500 |
| Balt USA, LLC | 9 | $1,028 |
| Canon Medical Systems USA, Inc. | 1 | $1,000 |
| Johnson & Johnson | 11 | $934 |
| Imperative Care, Inc | 2 | $828 |
| Depuy Synthes Products, Inc. | 2 | $602 |
| Phenox Inc. | 4 | $427 |
| MIVI Neuroscience, Inc. | 1 | $221 |
| Asahi Intecc USA, Inc. | 1 | $136 |
| Biosense Webster, Inc. | 1 | $104 |
| Neurovasc Technologies, Inc. | 2 | $56 |
| Siemens Medical Solutions USA, Inc. | 1 | $27 |
| Biogen | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EMBOGUARD$60,701
- SURPASS EVOLVE$33,526
- COMANECI 17$32,500
- TIGERTRIEVER 17 REVASCULARIZATION DEVICE$32,500
- TGS$19,489
- TARGET$18,971
- TREVO$11,619
- PULSERIDER$10,603
- EMBOTRAP II Revascularization Device$9,555
- SYNCHRO SELECT$8,900
- AXS CATALYST 7$7,775
- AXS VECTA 71$7,665
- Pipeline$3,813
- FLOWGATE2$3,600
- Echelon$2,975
- Embotrap$2,562
- Pulsar Vascular PulseRider Aneurysm Neck Reconstruction Device$2,224
- TRUFILL$2,224
- Benchmark$2,000
- PRADAXA$1,500
How this compares
$921,421 in reported general payments places this provider in the 95th percentile of 504 vascular & interventional radiology providers in California.
See all vascular & interventional radiology providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other vascular & interventional radiology in Los Angeles
- Keith TerasakiLos Angeles$1.7M
- Edward LeeLos Angeles$1.7M
- Siddharth PadiaLos Angeles$1.6M
- John MoriartyLos Angeles$719K
- Navid EghbaliehLos Angeles$639K
- Steven RamanLos Angeles$419K
- Justin McWilliamsLos Angeles$355K
- Jessica StewartLos Angeles$322K
- Ravi SrinivasaLos Angeles$279K
- Gary DuckwilerLos Angeles$237K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.